Cargando…
Establishing standardized immune phenotyping of metastatic melanoma by digital pathology
CD8+ tumor-infiltrating T cells can be regarded as one of the most relevant predictive biomarkers in immune-oncology. Highly infiltrated tumors, referred to as inflamed (clinically “hot”), show the most favorable response to immune checkpoint inhibitors in contrast to tumors with a scarce immune inf...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8590976/ https://www.ncbi.nlm.nih.gov/pubmed/34446805 http://dx.doi.org/10.1038/s41374-021-00653-y |
_version_ | 1784599108985552896 |
---|---|
author | Sobottka, Bettina Nowak, Marta Frei, Anja Laura Haberecker, Martina Merki, Samuel Levesque, Mitchell P. Dummer, Reinhard Moch, Holger Koelzer, Viktor Hendrik |
author_facet | Sobottka, Bettina Nowak, Marta Frei, Anja Laura Haberecker, Martina Merki, Samuel Levesque, Mitchell P. Dummer, Reinhard Moch, Holger Koelzer, Viktor Hendrik |
author_sort | Sobottka, Bettina |
collection | PubMed |
description | CD8+ tumor-infiltrating T cells can be regarded as one of the most relevant predictive biomarkers in immune-oncology. Highly infiltrated tumors, referred to as inflamed (clinically “hot”), show the most favorable response to immune checkpoint inhibitors in contrast to tumors with a scarce immune infiltrate called immune desert or excluded (clinically “cold”). Nevertheless, quantitative and reproducible methods examining their prevalence within tumors are lacking. We therefore established a computational diagnostic algorithm to quantitatively measure spatial densities of tumor-infiltrating CD8+ T cells by digital pathology within the three known tumor compartments as recommended by the International Immuno-Oncology Biomarker Working Group in 116 prospective metastatic melanomas of the Swiss Tumor Profiler cohort. Workflow robustness was confirmed in 33 samples of an independent retrospective validation cohort. The introduction of the intratumoral tumor center compartment proved to be most relevant for establishing an immune diagnosis in metastatic disease, independent of metastatic site. Cut-off values for reproducible classification were defined and successfully assigned densities into the respective immune diagnostic category in the validation cohort with high sensitivity, specificity, and precision. We provide a robust diagnostic algorithm based on intratumoral and stromal CD8+ T-cell densities in the tumor center compartment that translates spatial densities of tumor-infiltrating CD8+ T cells into the clinically relevant immune diagnostic categories “inflamed”, “excluded”, and “desert”. The consideration of the intratumoral tumor center compartment allows immune phenotyping in the clinically highly relevant setting of metastatic lesions, even if the invasive margin compartment is not captured in biopsy material. |
format | Online Article Text |
id | pubmed-8590976 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Nature Publishing Group US |
record_format | MEDLINE/PubMed |
spelling | pubmed-85909762021-11-23 Establishing standardized immune phenotyping of metastatic melanoma by digital pathology Sobottka, Bettina Nowak, Marta Frei, Anja Laura Haberecker, Martina Merki, Samuel Levesque, Mitchell P. Dummer, Reinhard Moch, Holger Koelzer, Viktor Hendrik Lab Invest Article CD8+ tumor-infiltrating T cells can be regarded as one of the most relevant predictive biomarkers in immune-oncology. Highly infiltrated tumors, referred to as inflamed (clinically “hot”), show the most favorable response to immune checkpoint inhibitors in contrast to tumors with a scarce immune infiltrate called immune desert or excluded (clinically “cold”). Nevertheless, quantitative and reproducible methods examining their prevalence within tumors are lacking. We therefore established a computational diagnostic algorithm to quantitatively measure spatial densities of tumor-infiltrating CD8+ T cells by digital pathology within the three known tumor compartments as recommended by the International Immuno-Oncology Biomarker Working Group in 116 prospective metastatic melanomas of the Swiss Tumor Profiler cohort. Workflow robustness was confirmed in 33 samples of an independent retrospective validation cohort. The introduction of the intratumoral tumor center compartment proved to be most relevant for establishing an immune diagnosis in metastatic disease, independent of metastatic site. Cut-off values for reproducible classification were defined and successfully assigned densities into the respective immune diagnostic category in the validation cohort with high sensitivity, specificity, and precision. We provide a robust diagnostic algorithm based on intratumoral and stromal CD8+ T-cell densities in the tumor center compartment that translates spatial densities of tumor-infiltrating CD8+ T cells into the clinically relevant immune diagnostic categories “inflamed”, “excluded”, and “desert”. The consideration of the intratumoral tumor center compartment allows immune phenotyping in the clinically highly relevant setting of metastatic lesions, even if the invasive margin compartment is not captured in biopsy material. Nature Publishing Group US 2021-08-26 2021 /pmc/articles/PMC8590976/ /pubmed/34446805 http://dx.doi.org/10.1038/s41374-021-00653-y Text en © The Author(s) 2021, corrected publication 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Sobottka, Bettina Nowak, Marta Frei, Anja Laura Haberecker, Martina Merki, Samuel Levesque, Mitchell P. Dummer, Reinhard Moch, Holger Koelzer, Viktor Hendrik Establishing standardized immune phenotyping of metastatic melanoma by digital pathology |
title | Establishing standardized immune phenotyping of metastatic melanoma by digital pathology |
title_full | Establishing standardized immune phenotyping of metastatic melanoma by digital pathology |
title_fullStr | Establishing standardized immune phenotyping of metastatic melanoma by digital pathology |
title_full_unstemmed | Establishing standardized immune phenotyping of metastatic melanoma by digital pathology |
title_short | Establishing standardized immune phenotyping of metastatic melanoma by digital pathology |
title_sort | establishing standardized immune phenotyping of metastatic melanoma by digital pathology |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8590976/ https://www.ncbi.nlm.nih.gov/pubmed/34446805 http://dx.doi.org/10.1038/s41374-021-00653-y |
work_keys_str_mv | AT sobottkabettina establishingstandardizedimmunephenotypingofmetastaticmelanomabydigitalpathology AT nowakmarta establishingstandardizedimmunephenotypingofmetastaticmelanomabydigitalpathology AT freianjalaura establishingstandardizedimmunephenotypingofmetastaticmelanomabydigitalpathology AT habereckermartina establishingstandardizedimmunephenotypingofmetastaticmelanomabydigitalpathology AT merkisamuel establishingstandardizedimmunephenotypingofmetastaticmelanomabydigitalpathology AT establishingstandardizedimmunephenotypingofmetastaticmelanomabydigitalpathology AT levesquemitchellp establishingstandardizedimmunephenotypingofmetastaticmelanomabydigitalpathology AT dummerreinhard establishingstandardizedimmunephenotypingofmetastaticmelanomabydigitalpathology AT mochholger establishingstandardizedimmunephenotypingofmetastaticmelanomabydigitalpathology AT koelzerviktorhendrik establishingstandardizedimmunephenotypingofmetastaticmelanomabydigitalpathology |